Results for china-based sinovac biotech

Add to feed Create your own feed

Latest

The vaccine developed by China-based Sinovac BioTech showed “remarkable” safety results across all age groups, including the elderly, according to the DOST-Vaccine Expert Panel. | @CMRamosINQ 

The safety of CoronaVac, the COVID-19 vaccine developed by China-based Sinovac BioTech, showed “remarkable” results across all age groups, including the elderly, according to the head of the vaccine development expert panel of DOST. | @CMRamosINQ 

A total of 9,043 soldiers have so far been immunized against COVID-19 using CoronaVac, the vaccine developed by China-based Sinovac BioTech, Defense Secretary Delfin Lorenzana said Thursday. | @dygalvezINQ 

A total of 600,000 doses of China-based Sinovac Biotech’s Covid-19 vaccine are set to arrive in the country on Feb. 23, Malacañang announced on Thursday. | @dygalvezINQ 

Indonesia’s government says 1.2 million doses of a COVID-19 vaccine developed by China-based biopharmaceutical company Sinovac Biotech arrived in the country.

Anvisa, Brazil’s health care surveillance agency, restarted phase III trials for Coronavac, the COVID-19 vaccine candidate developed by China-based Sinovac Biotech, after a suspension of just two days.

Anvisa, Brazil’s health care surveillance agency, has halted the final-stage trials for Beijing, China-based Sinovac Biotech's COVID-19 vaccine candidate Coronavac after a serious adverse event occurred on Oct. 29

The government is set to increase Bio Farma’s production capacity as soon as a third clinical trial of China-based biopharmaceutical company Sinovac Biotech’s COVID-19 vaccine is finished and successful. #jakpost 

The DOH has identified five hospitals which will be the site of clinical trials of China-based Sinovac Biotech’s vaccine against the coronavirus disease. | @dygalvezINQ 

Indonesia on Tuesday began the final-phase clinical trial for a potential coronavirus vaccine being developed by China-based Sinovac Biotech Ltd. #BangkokPost  #World  #vaccine 

Loading
Loading